Found 1872 clinical trials
At-Risk for Type 1 Diabetes Extension Study
This study is an extension of the NIH-sponsored AT-Risk (TN-10) type 1 diabetes study (NCT 01030861). Teplizumab-treated and placebo-treated participants in the NIH trial who develop clinical type 1 diabetes after the conclusion of that trial, are eligible to enroll and receive teplizumab treatment within one year of diagnosis of …
- 0 views
- 16 Feb, 2024
- 5 locations
- 0 views
- 09 Nov, 2022
- 1 location
Scripps Digital Diabetes: Cloud-Based Continuous Glucose Monitoring (CB CGM)
Individuals with diabetes in the hospital often experience poor glycemic control, which places them at greater risk for infection, neurological and cardiac complications, mortality, longer lengths of stay, readmissions, and higher healthcare costs.
- 0 views
- 16 Feb, 2024
- 1 location
Reduced Occupational Sitting in Type 2 Diabetes Using mHealth (Mobile Health)
Type 2 diabetes mellitus (T2DM) patients are suboptimal treated due to low uptake of physical activity. Recent research shows promising beneficial health effects from reducing sitting time by regular short bouts of light-intensity physical activity.
- 0 views
- 16 Feb, 2024
- 1 location
Inhaled Nitric Oxide for Preventing Progression in COVID-19
This is a pilot randomized-controlled (2:1) open label investigation of inhaled NO to prevent progression to more advanced disease in 42 hospitalized patients with COVID-19, at risk for worsening, based on baseline systemic oxygenation and 2 or more of the major risk factors of age > 60 years, type II …
- 0 views
- 05 Aug, 2020
UPENN Case Test Trial 2 (Do Not Make Any Changes)
UPENN Case Test Trial 2 (Do Not Make Any Changes)
- 0 views
- 24 Apr, 2025
UPENN Case Test Trial 7 (Do Not Make Any Changes)
UPENN Case Test Trial 7 (Do Not Make Any Changes)
- 0 views
- 24 Apr, 2025
- 1 location
UPENN Case Test Trial 12 (Do Not Make Any Changes)
UPENN Case Test Trial 12 (Do Not Make Any Changes)
- 0 views
- 24 Apr, 2025
- 1 location